These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20537815)

  • 1. Effects of experimental Unemployment, Employment and Punishment analogs on opioid seeking and consumption in heroin-dependent volunteers.
    Greenwald MK
    Drug Alcohol Depend; 2010 Sep; 111(1-2):64-73. PubMed ID: 20537815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of alternative reinforcer magnitude and post-session drug supply.
    Greenwald MK; Steinmiller CL
    Drug Alcohol Depend; 2009 Sep; 104(1-2):84-93. PubMed ID: 19464125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of unit price and pre-session drug supply.
    Greenwald MK; Hursh SR
    Drug Alcohol Depend; 2006 Oct; 85(1):35-48. PubMed ID: 16616994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yohimbine increases opioid-seeking behavior in heroin-dependent, buprenorphine-maintained individuals.
    Greenwald MK; Lundahl LH; Steinmiller CL
    Psychopharmacology (Berl); 2013 Feb; 225(4):811-24. PubMed ID: 23161001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid reinforcement in heroin-dependent volunteers during outpatient buprenorphine maintenance.
    Greenwald MK; Johanson CE; Schuster CR
    Drug Alcohol Depend; 1999 Oct; 56(3):191-203. PubMed ID: 10529021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers.
    Greenwald MK; Lundahl LH; Steinmiller CL
    Neuropsychopharmacology; 2010 Dec; 35(13):2624-37. PubMed ID: 20881947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of buprenorphine sublingual tablet maintenance on opioid drug-seeking behavior by humans.
    Greenwald MK; Schuh KJ; Hopper JA; Schuster CR; Johanson CE
    Psychopharmacology (Berl); 2002 Apr; 160(4):344-52. PubMed ID: 11919661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices.
    Greenwald M; Johanson CE; Bueller J; Chang Y; Moody DE; Kilbourn M; Koeppe R; Zubieta JK
    Biol Psychiatry; 2007 Jan; 61(1):101-10. PubMed ID: 16950210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans.
    Comer SD; Collins ED; Fischman MW
    Psychopharmacology (Berl); 2001 Feb; 154(1):28-37. PubMed ID: 11292003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers.
    Comer SD; Walker EA; Collins ED
    Psychopharmacology (Berl); 2005 Oct; 181(4):664-75. PubMed ID: 16025322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers.
    Greenwald MK; Johanson CE; Moody DE; Woods JH; Kilbourn MR; Koeppe RA; Schuster CR; Zubieta JK
    Neuropsychopharmacology; 2003 Nov; 28(11):2000-9. PubMed ID: 12902992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period.
    Correia CJ; Walsh SL; Bigelow GE; Strain EC
    Psychopharmacology (Berl); 2006 Dec; 189(3):297-306. PubMed ID: 17013637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of buprenorphine initial outpatient maintenance and dose taper response among non-treatment-seeking heroin dependent volunteers.
    Woodcock EA; Lundahl LH; Greenwald MK
    Drug Alcohol Depend; 2015 Jan; 146():89-96. PubMed ID: 25479914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder.
    Nasser AF; Greenwald MK; Vince B; Fudala PJ; Twumasi-Ankrah P; Liu Y; Jones JP; Heidbreder C
    J Clin Psychopharmacol; 2016 Feb; 36(1):18-26. PubMed ID: 26650971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals.
    Huhn AS; Strain EC; Bigelow GE; Smith MT; Edwards RR; Tompkins DA
    Anesthesiology; 2019 Jan; 130(1):131-141. PubMed ID: 30418214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans.
    Comer SD; Collins ED; MacArthur RB; Fischman MW
    Psychopharmacology (Berl); 1999 Apr; 143(4):327-38. PubMed ID: 10367549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers.
    Zacny JP; Gutierrez S
    Drug Alcohol Depend; 2009 Apr; 101(1-2):107-14. PubMed ID: 19118954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers.
    Comer SD; Sullivan MA; Whittington RA; Vosburg SK; Kowalczyk WJ
    Neuropsychopharmacology; 2008 Apr; 33(5):1179-91. PubMed ID: 17581533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid craving and seeking behavior in physically dependent volunteers: effects of acute withdrawal and drug reinforcement opportunity.
    Greenwald MK
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):3-14. PubMed ID: 15727498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans.
    Walsh SL; Strain EC; Abreu ME; Bigelow GE
    Psychopharmacology (Berl); 2001 Sep; 157(2):151-62. PubMed ID: 11594439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.